Faculty Information - KATAOKA Hiroshi

（Last updated : 2024-04-12 11:53:38）

KATAOKA Hiroshi
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Nephrology

Position Assistant Professor

■ Published papers

1.	Case report	PLA2R-positive membranous nephropathy in IgG4-related disease 2024/02/23
2.	Original article	Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney disease 2024/02/05
3.	Original article	Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease 2024/01
4.	Original article	Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD. 2023/11/03
5.	Original article	Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease. 2023/10
6.	Original article	Glomerular hyperfiltration and hypertrophy: an evaluation of maximum values in pathological indicators to discriminate "diseased" from "normal" 2023/07/13
7.	Review article	Visceral fat and attribute-based medicine in chronic kidney disease. 2023/02
8.	Original article	Machine learning for morbid glomerular hypertrophy. 2022/11
9.	Original article	Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease 2022/10/27
10.	Original article	Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease. 2022/06
11.	Original article	Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polystic Kidney Disease 2022/05/20
12.	Original article	Slowly Progressive Male Alport Syndrome Evaluated by Serial Biopsy: Importance of Type IV Collagen Staining. 2022/04
13.	Original article	Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study 2022/03/08
14.	Original article	Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease 2022/01/29
15.	Original article	Germline Mutations for Kidney Volume in ADPKD 2021/12/13
16.	Original article	Slowly Progressive Male Alport Syndrome Evaluated by Serial Biopsy:Importance of Type ⅣCollagen 2021/10/12
17.	Original article	Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD 2021/07/14
18.	Original article	Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease 2021/07
19.	Original article	Renal amyloidosis with monotypic IgM lambda deposition 2021/07
20.	Original article	Renal amyloidosis with monotypic IgM lambda deposition 2021/06/19
21.	Original article	Lupus Nephritis and Hydroxychloroquine-Associated Zebra Bodies: Not Just in Fabry Disease 2021/05
22.	Original article	Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease 2021/04/02
23.	Original article	The origin of urinary mulberry cells in Fabry 2021/04
24.	Original article	Impact of visceral fat area in patients with chronic kidney desease 2021/02/17
25.	Original article	Everolimus-associated focal segmental glomerulosclerosis in a liver transplant recipient 2020/12/09
26.	Original article	Cell invasion in glomerular basement membrane: infolding glomerulopathy 2020/12/06
27.	Original article	Sex Differences in Time-Series Changes in Pseudo-R²　Values Regarding Hyperuricemia in Relation to the Kidney Prognosis 2020/11/26
28.	Original article	Visceral to subcutaneous fat ratio as an indicator of a ≧30％　eGFR decline in chronic kidney disease 2020/11
29.	Original article	Impact of the number of steroid pulses in tonsillectomy combined with steroid pulse therapy: a nationwide retrospective study in Japan 2020/09/03
30.	Original article	Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes 2020/08
31.	Original article	A standardized protocol for the mulberry cells and mulberry bodies in the urinary sediment of Fabry disease 2020/07/11
32.	Original article	Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study. 2020/05/07
33.	Original article	Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease. 2020/04
34.	Original article	High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study 2020/03/10
35.	Original article	Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study. 2020/02/08
36.	Original article	Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations. 2020/01/05
37.	Original article	Impacts of Sex Differences in Pulse Pressure among Patients with Chronic Kidney Disease. 2019/12/09
38.	Original article	Proximal Tubulopathy With Fibrillary Inclusions: A Rare Manifestation of Lymphoma-Associated Monoclonal Gammopathy of Renal Significance(MGRS) 2019/10/17
39.	Original article	Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis. 2019/09
40.	Original article	Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome 2019/08/20
41.	Original article	A Body Mass Index-Based Cross-Classification Approach for the Assessment of Prognostic Factors in Chronic Kidney Disease Progression. 2019/06
42.	Original article	Mutation analyses by next-generation sequencing and multiplex ligation-dependent probe amplification in Japanese autosomal dominant polycystic kidney disease patients 2019/04
43.	Original article	Low HDL cholesterol as a predictor of chronic kidney disease progression:a cross-classification approach and matched cohort analysis. 2019/03
44.	Original article	PKD1 mutation may epistatically ameliorate nephronophthisis progression in patients with NPHP1 deletion 2019/01
45.	Original article	Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis:A case report. 2019/01
46.	Original article	Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. 2018/12
47.	Original article	Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD). 2018/10
48.	Original article	Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Repuired Surgical Treatment 2018/08
49.	Original article	A case of unilateral nephrectomy performed for autosomal dominant polycystic kidney disease with marked unilateral enlargement. 2018/05
50.	Original article	Large Renel Corpuscle:Clinical Significance of Evaluation of the Largest Renal Corpuscle in Kidney Biopsy Specimens. 2018/05
51.	Original article	New Insights into Cystic Kidney Diseases. 2018/05
52.	Original article	Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. 2018/03
53.	Original article	Serum Soluble(Pro)Renin Receptor Level is Increased in Association with Impaired Renal Function in Patients with Autosomal Dominant Polycystic Kedney Disease 2018/02
54.	Original article	A case of unilateral nephrectomy performed for autosomal dominant polycystic kidney disease with marked unilateral enlargement 2018/01
55.	Original article	Fibroblast growth factor 23 and soluble Klotho in patients with autosomal dominant polycystic kidney disease. 2017/11
56.	Original article	Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. 2017/06
57.	Original article	Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis:Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. 2017/01
58.	Original article	Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis:Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. 2016/10
59.	Original article	Fibroblast growth factor 23 and soluble Klotho in patients with autosomal dominant polycystic kidney disease. 2016/07
60.	Original article	Relationship between variations in time-dependent response to erythropoiesis-stimulating agents and mortality in hemodialysis patients: a single-center study 2016/02
61.	Original article	Inhibitory Effect of Serotonin Antagonist on Leukocyte-Endothelial Interactions In Vivo and In Vitro. 2016
62.	Original article	Relationship between anaemia management at haemodialysis initiation and patient prognosis. 2015/12
63.	Original article	Relationship between anemia management at hemodialysis initiation and patient prognosis. 2015/10
64.	Original article	High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a. 2015/08
65.	Original article	Associations between the erythropoiesis-stimulating agent resistance index and the geriatric nutritional risk index of maintenance hemodialysis patients and increased mortality 2015/01
66.	Original article	Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. 2014/12
67.	Original article	Serum Hepcidin Levels and Reticulocyte Hemoglobin Concentrations as Indicators of the Iron Status of Peritoneal Dialysis Patients 2012/09
68.	Original article	Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters 2012/02
69.	Original article	Maximal glomeular diameter as a 10-year prognostic indicator for IgA nephropathy 2011
Display 5 items
Display all(69)

■ Academic conference presentation

1.	Prevalence and characteristics of intracranial aneurysms and cerebral hemorrhage in patients with autosomal dominant polycystic kidney disease in the Japanese nationwide database 2023/11/04
2.	High hemoglobin and high ESA responsiveness are good prognostic factors in CKD patients: An attribute-based analysis using a cross-classification approach in the BRIGHTEN study 2023/11/02
3.	Relationship of tolvaptan dose with the rate of decline in kidney function in ADPKD patients. 2019/11/07
4.	Clinical and histopathological assessment of hyperuricemia as a predictive marker for progression of nephrosclerosis 2018/02/22
5.	Considering cut off value of waist circumference as a metabolic syndrome component from the point of renal function decline 2018/02/22
6.	Hyperuricemia as a predictor of progression of chronic kidney disease:A matched cohort analysis 2018/02/22
7.	Maximum glomerular/renal corpuscle diameter as a potential prognostic predictor for IgA nephropathy, correlated with obesity/overweight 2018/02/22
8.	Pulse pressure as a predictor of ≥30% eGFR decline or ESRD in patients with CKD. 2018/02/22
9.	Relationship between maximum glomerular/renal corpuscle diameters with serum complement 3 in IgA nephropathy 2018/02/22
10.	Relationship between maximum renal corpuscle diameter with clinical and histopathological pathological factors in IgA nephropathy 2018/02/22
11.	Relationship between pulse pressure and ≥50% eGFR decline or ESRD in CKD patients without diabetes mellitus 2018/02/22
12.	Urine AQP2 Is One of the Candidates for a Surrogate Maker in the Treatment of ADPKD Patients by Tolvaptan 2015/11
13.	PROGNOSIS IN IgA NEPHROPATHY: 30-YEAR ANALYSIS OF 1,012 PATIENTS AT A SINGLE CENTER IN JAPAN 2014/05/17
14.	DAMAGE ASSESSMENT IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS IN JAPAN USED BY VASCULITIS DAMAGE INDEX (VDI) 2014/05/16
15.	THE RELATIONSHIP BETWEEN MAXIMAL GLOMERULAR DIAMETER (MAX GD) WITH CLINICAL AND HISTOPATHOLOCICAL FACTORS IN IGA NEPHROPATHY 2014/05/15
16.	Serotonin Antagonist Inhibits Leukocyte-endothelial Interactions In Vivo And In Vitro: Potential contribution Of Pkc-dependent Pathway. 2012/11/05
Display 5 items
Display all(16)

■ Education

1.		Faculty of Medicine, Tokyo Women's Medical University,
2.	1997/04～2003/03	Faculty of Medicine, Kagoshima University, Graduated
3.	1990/04～1994/03	Faculty of Laws, Kyoto University, Graduated